Status:
UNKNOWN
Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)
Lead Sponsor:
Sheba Medical Center
Conditions:
Diffuse Parenchymal Lung Disease
Eligibility:
All Genders
18-85 years
Brief Summary
The primary intention of this study is to determine the diagnostic performance of ultra-low-dose CT (ULDCT) in diagnosis and follow-up of diffuse parenchymal lung disease (DPLD). We hypothesize that i...
Eligibility Criteria
Inclusion
- suspected or known DPLD
- referred to DPLD observation
Exclusion
- 1\. other lung related diseases
- \-
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04392726
Start Date
August 1 2020
End Date
January 30 2024
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel